myositis Dotaz Zobrazit nápovědu

We are showing a case of the myositis ossificans, appearing after the dissection of axilla simulating a metastasis of a malignant melanoma. In these circumstances this is a very rare case. It can, however, lead to an unnecessary operation. For this reason it should be useful to bera this possibility in mind.

MeSH
axila chirurgie MeSH
diferenciální diagnóza MeSH
lidé středního věku MeSH
lidé MeSH
lymfadenektomie škodlivé účinky MeSH
melanom patologie sekundární chirurgie MeSH
myositis ossificans etiologie MeSH
nádory kůže patologie MeSH
Check Tag
lidé středního věku MeSH
lidé MeSH
mužské pohlaví MeSH
Publikační typ
anglický abstrakt MeSH
časopisecké články MeSH
kazuistiky MeSH

Článek

Vzácný p6räpad myositis ossificans traumatica permagna
[Unusual case of extensive myositis ossificans traumatica]

HANAK, F
Autor HANAK, F

Lekarske listy. 1951 Oct 15 ; 6 (20) : 613-15.

Lek List
Lekarske listy | Lek List
Zdroj

Článek

P R'ISP EVEK K HETEROTOPICK'YM OSIFIKAC'IM. (TZV. TUMORIFORMN'I OSIFIKUJ'IC'I MYOSITIS)
[CONTRIBUTION TO HETEROTOPIC OSSIFICATION (SO-CALLED TUMOR-LIKE OSSIFYING MYOSITIS)]

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca. 1963 Oct ; 30 () : 406-8.

Acta Chir Orthop Traumatol Cech
ISSN 0001-5415
Zdroj

Klíčová slova
CHILD *, DIAGNOSIS, DIFFERENTIAL *, MYOSITIS OSSIFICANS *, NEOPLASM DIAGNOSIS *, RADIOGRAPHY *, SARCOMA *, THIGH *,
MeSH
diferenciální diagnóza * MeSH
dítě MeSH
heterotopická osifikace * MeSH
lidé MeSH
myositis ossificans * MeSH
myozitida * MeSH
nádory diagnóza MeSH
rentgendiagnostika * MeSH
sarkom * MeSH
stehno * MeSH
Check Tag
dítě MeSH
lidé MeSH
Publikační typ
časopisecké články MeSH

Článek

The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis

Idiopathic inflammatory myopathies (IIM), or myositis, are a heterogeneous group of systemic autoimmune ...

Clinical and experimental rheumatology. 2025 Feb ; 43 (2) : 202-210. [epub] 20250220

Clin Exp Rheumatol
ISSN 0392-856X
Zdroj

Idiopathic inflammatory myopathies (IIM), or myositis, are a heterogeneous group of systemic autoimmune disorders that are associated with significant morbidity and mortality. Conducting high-quality clinical trials in IIM is challenging due to the rare and variable presentations of disease. To address this challenge, the Myositis Clinical Trials Consortium (MCTC) was formed. MCTC is a collaborative international alliance dedicated to facilitating, promoting, coordinating and conducting clinical trials and related research in IIM. This partnership works to advance the discovery of effective evidence-based treatments for IIM by integrating a diverse group of clinical investigators, research professionals, medical centres, patient groups, and industry partners. The Steering Committee, Core Group, and Paediatric Subcommittee of MCTC are comprised of myositis experts and junior investigators from around the world, representing a diversity of genders, geographies, and subspecialties. MCTC works alongside other current myositis organisations to complement existing work by concentrating on the operationalisation of clinical trials. Our pilot Myositis Investigators' Information Survey gathered responses from 173 myositis investigators globally and found considerable variability in proficiency with outcome measures, geographic disparities in patient recruitment, and a significant disconnect between investigators' routine myositis patient load and clinical trial enrolment. MCTC will meet the need to support and diversify myositis clinical trials by facilitating trial planning, feasibility assessments, site selection, and the training and mentoring of junior investigators/centres to establish their readiness for clinical trial participation. Through experienced leadership, strategic collaborations, and interdisciplinary discussions, MCTC will establish standards for IIM clinical trial design, protocols, and outcome measures in myositis.